Statement from the Commissioner of the U.S. Food and Drug Administration (FDA) on the agency’s efforts to address the opioid epidemic, including new packaging intended to reduce new addiction and the release of the Opioid Analgesic REMS Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain.
Source link
Statement from FDA Commissioner Scott Gottlieb, M.D., On New Steps To Help Prevent New Addiction, Curb Abuse and Overdose Related to Opioid Products
“Glee” Star Amber Riley On Messing Up In Front Of Stevie Wonder
Drake vs. Kendrick Lamar: A Brief History Of A Beef
Ncuti Gatwa Begins Historic Run as Doctor Who’s First Black Doctor
The Netflix “Good Times” Reboot Is A Not So Good Time
